List novel drug delivery systems for each topical, oral, vaginal, ophthalmic, and parenteral route.
Novel Drug Delivery System is a release of drug to a specific
site with specific cost using advanced approach, formula,
technology using the chemical compound for body safely achieve its
therapeutic effects.
Topical:
-Aerosol foams for acne vulgaris
-liposomes to control the skin layer
-Nanoemulsions for acne to increase the penetration of the active
compounds, skin hydration and viscoelasticity
Oral:
- Osmotic controlled release oral delivery system
-Glucotrol XL
-Procardia XL
-layered tablets
-Ion exchange resins
-Gel-cap
-Polymer precipitation technology
Vaginal:
-bioadhesive tablets
-liposomes
-microparticles
-hydrophillic dryer,
-vaginal absorption of steroids
-antimicrobial proteins
-prostaglandins
-nonxynol
-peptides
Ophthalmic:
- Epinehrinel
-phenylephrine
-timolol
-pilocarpine
-albuterol
-bioadhesive polymer
-oil in water emulsions
-nanoparticles, niosomes, liposomes
-carbopol 1342-coated pilocarpine,
-iontophoresis
Parenteral:
- solid lipid nanoparticles
-semi-solid polymers
-organo gels
-lipid nanodispersions
-nanoemulsions
-niosomes
-nanosuspensions
-liposomes
-
List novel drug delivery systems for each topical, oral, vaginal, ophthalmic, and parenteral route.
Define aerosols, inhalations, and sprays drug delivery and list drugs typically administered in each.
1. (15 pts) Drug Delivery What are four types of hydrogels discussed in class, and list an advantage and disadvantage of each. a) b) What is zero-order controlled release and why is it desirable? c) Rank all available drug delivery routes in terms of increasing patient compliance and explain why.
1. (15 pts) Drug Delivery What are four types of hydrogels discussed in class, and list an advantage and disadvantage of each. a) b) What is zero-order controlled release and...
Title: Partners Health Care Systems (PHS): Transforming Health Care Services Delivery through Information Management According to government sources, U.S. expenditures on health care in 2009 reached nearly $2.4 trillion dollars ($2.7 trillion by the end of 2010).[1] Despite this vaunting national level of expenditure on medical treatment, death rates due to preventable errors in the delivery of health services rose to approximately 98,000 deaths in 2009.[2] To address the dual challenges of cost control and quality improvement, some have argued...